13 results match your criteria: "Koc University IsBank Research Center for Infectious Diseases (KUISCID)[Affiliation]"
Bioanalysis
November 2024
Sabanci University Nanotechnology Research & Application Center (SUNUM), Istanbul, 34956, Turkey.
Serological studies with pseudotyped viruses offer a safer alternative to live SARS-CoV-2 in evaluating neutralizing antibodies, enabling research in standard labs. The SARS-CoV-2 Spike pseudotyped vesicular stomatitis virus (VSV) pseudoviruses were generated using Spike of Wuhan strain and two variants (B.1.
View Article and Find Full Text PDFInfect Dis Clin Microbiol
June 2024
Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, İstanbul, Türkiye.
BMC Pregnancy Childbirth
June 2024
Koç University İşBank Research Center for Infectious Diseases (KUISCID), Istanbul, Turkey.
Objective: The vaginal microbiota dysbiosis induces inflammation in the uterus that triggers tissue damage and is associated with preterm birth. Progesterone is used to prevent labor in pregnant women at risk of preterm birth. However, the mechanism of action of progesterone still needs to be clarified.
View Article and Find Full Text PDFArch Gynecol Obstet
July 2024
Department of Obstetrics and Gynecology, School of Medicine, Koc University, Zeytinburnu, Istanbul, Turkey.
Background: The vaginal microbiota plays a significant role in pregnancy outcomes and newborn health. Indeed, the composition and diversity of the vaginal microbiota can vary among different ethnic groups. Our study aimed to investigate the composition of the vaginal microbiome throughout the three trimesters of pregnancy and to identify any potential variations or patterns in the Turkish population compromising mixed ethnicities.
View Article and Find Full Text PDFInfect Dis Clin Microbiol
December 2023
Koç University IsBank Research Center for Infectious Diseases (KUISCID), İstanbul, Türkiye.
Infect Dis Clin Microbiol
September 2023
Koç University IsBank Research Center for Infectious Diseases (KUISCID), İstanbul, Türkiye.
In this study, we aimed to investigate the changes in the B cell subpopulations after homologous or heterologous COVID-19 boosters. Blood samples were collected after baseline (3-5 months after two doses of CoronaVac), 1 and 3 months after BNT162b2 (n=28 and n=6), and CoronaVac (n=7 and n=4) boosters. Peripheral blood mononuclear cells (PBMCs) were isolated and stained with B cell markers, the ratios of naïve (CD19+CD20+CD27-), memory (CD19+CD20+CD27+), memory B cells expressing IgG (CD19+CD20+CD27+IgG+), and effector memory B cells (CD19+CD20+CD27+CD38+) were identified with flow cytometry.
View Article and Find Full Text PDFInfect Dis Clin Microbiol
March 2024
Koç University İşbank Research Center for Infectious Diseases (KUISCID), İstanbul, Türkiye.
This study examines the effects of the bundle of antimicrobial stewardship measures for prophylactic antibiotics among thoracic surgery patients. A local protocol, based on current guidelines starting from December 2014, was developed by the Infection Control and Thoracic Surgery Teams. The effects of this protocol were assessed by monitoring a total of 1380 patients before and after its implementation from January 1, 2011, to December 31, 2022.
View Article and Find Full Text PDFSci Rep
March 2023
Departments of Biophysics, Faculty of Medicine, Ankara University, Ankara, 06230, Turkey.
Coronavirus Disease-19 (COVID-19) is a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The development of rapid antigen tests has contributed to easing the burden on healthcare and lifting restrictions by detecting infected individuals to help prevent further transmission of the virus. We developed a state-of-art rapid antigen testing system, named DIAGNOVIR, based on immune-fluorescence analysis, which can process and give the results in a minute.
View Article and Find Full Text PDFJ Med Virol
January 2023
Department of Medical Microbiology, School of Medicine, Koc University, Istanbul, Turkey.
The maintenance of vaginal microbiota is an important factor to achieve optimum pregnancy outcomes. The study aims to describe the alterations in the composition of vaginal microbiota in pregnant women with coronavirus disease 2019 (COVID-19). This was a prospective case-control study.
View Article and Find Full Text PDFBackground: It is essential to know about immune response levels after booster doses of the two different types of vaccines, mRNA, and the inactivated, currently used against COVID-19. For this purpose, we aimed to determine the effects of BNT162b2 (BNT) and CoronaVac (CV) boosters on the humoral and cellular immunity of individuals who had two doses of CV vaccination.
Methods: The study was conducted in three centers (Koc University Hospital, Istanbul University Cerrahpasa Hospital, and Istanbul University, Istanbul Medical School Hospital) in Istanbul, Turkey.
Clin Microbiol Infect
June 2022
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses, Basel, Switzerland; Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany. Electronic address:
Scope: The objective of these guidelines is to identify the most appropriate diagnostic test and/or diagnostic approach for SARS-CoV-2. The recommendations are intended to provide guidance to clinicians, clinical microbiologists, other health care personnel, and decision makers.
Methods: An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee.
Placenta
January 2022
Koc University, School of Medicine, Department of Medical Microbiology, Turkey; Koç University İşBank Research Center for Infectious Diseases (KUISCID), Istanbul, Turkey. Electronic address:
Introduction: Maternal anti-SARS-CoV-2 Spike antibodies can cross the placenta during pregnancy, and neonates born to infected mothers have acquired antibodies at birth. Few studies reported data on the histopathological changes of the placenta during infection and placental infection. SARS-CoV-2 infection may cause impaired development of the placenta, thus predisposing maternal and fetal unfavorable outcomes.
View Article and Find Full Text PDF